Meeting
2024 ASCO Quality Care Symposium
Racial representation in multicenter clinical trials leading to drug approvals for gynecological cancer indications by the US Food and Drug Administration (FDA).
Authors
Kristen R. Ibanez
Women’s Malignancies Branch, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, MD
Kristen R. Ibanez , Maheen Khan , Duncan Donohue , Ann Oluloro , Elizabeth M. Swisher , Jung-Min Lee
Disclaimer
This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org
Poster Details
Session Type
Poster Session
Session Title
Poster Session B
Track
Health Care Access, Equity, and Disparities,Technology and Innovation in Quality of Care,Survivorship
Sub Track
Access to Clinical Trials
Citation
JCO Oncol Pract 20, 2024 (suppl 10; abstr 66)
DOI
10.1200/OP.2024.20.10_suppl.66
Abstract #
66
Poster Bd #
A16
Abstract Disclosures